NGL Fine-Chem Ltd. | Income Statement

Fiscal year is April-March. All values INR Millions.
2014
2015
2016
2017
2018
Sales/Revenue
784
863
948
965
1,137
Cost of Goods Sold (COGS) incl. D&A
629
668
667
689
688
Gross Income
155
195
282
276
449
SG&A Expense
69
90
103
88
281
EBIT
84
104
192
225
168
Unusual Expense
7
19
-
-
-
Non Operating Income/Expense
5
20
1
4
26
Interest Expense
16
15
16
10
16
Pretax Income
67
129
179
220
178
Income Tax
22
45
65
78
52
Consolidated Net Income
45
83
114
142
126
Net Income
45
83
114
142
126
Net Income After Extraordinaries
45
83
114
142
126
Net Income Available to Common
45
83
114
142
126
EPS (Basic)
7.33
13.48
18.45
23.05
20.38
Basic Shares Outstanding
6
6
6
6
-
EPS (Diluted)
7.33
13.48
18.45
23.05
-
Diluted Shares Outstanding
6
6
6
6
-
EBITDA
108
130
220
256
213
Other Operating Expense
1
1
14
37
-
Non-Operating Interest Income
1
1
1
1
-

About NGL Fine-Chem

View Profile
Address
301, East Square
Mumbai Maharashtra 400057
India
Employees -
Website http://www.nglfinechem.com
Updated 09/14/2018
NGL Fine-Chem Ltd. manufactures pharmaceuticals and intermediates for usage in veterinary and human health. Its products include API animal and human health, intermediates, and finished dosage form. The company was founded on December 18, 1981 and is headquartered in Mumbai, India.